Cargando…
BSG and MCT1 Genetic Variants Influence Survival in Multiple Myeloma Patients
Multiple myeloma (MM) is a haematologic malignancy characterized by the presence of atypical plasma cells. Basigin (BSG, CD147) controls lactate export through the monocarboxylic acid transporter 1 (MCT1, SLC16A1) and supports MM survival and proliferation. Additionally, BSG is implicated in respons...
Autores principales: | Łacina, Piotr, Butrym, Aleksandra, Mazur, Grzegorz, Bogunia-Kubik, Katarzyna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5977166/ https://www.ncbi.nlm.nih.gov/pubmed/29695106 http://dx.doi.org/10.3390/genes9050226 |
Ejemplares similares
-
Soluble CD147 (BSG) as a Prognostic Marker in Multiple Myeloma
por: Łacina, Piotr, et al.
Publicado: (2022) -
BSG (CD147) Serum Level and Genetic Variants Are Associated with Overall Survival in Acute Myeloid Leukaemia
por: Łacina, Piotr, et al.
Publicado: (2022) -
Telomere length and hTERT genetic variants as potential prognostic markers in multiple myeloma
por: Dratwa, Marta, et al.
Publicado: (2023) -
Cereblon and IRF4 Variants Affect Risk and Response to Treatment in Multiple Myeloma
por: Butrym, Aleksandra, et al.
Publicado: (2017) -
TERT genetic variability and telomere length as factors affecting survival and risk in acute myeloid leukaemia
por: Dratwa, Marta, et al.
Publicado: (2021)